Terumo Aortic announced enrollment of the first patient in the fenestrated TREO pivotal trial in the United States. Accordi ...

RapidAI announced FDA clearance of Aortic Management, part of the company’s Rapid Aortic product, a clinical artificial ...

Surmodics, Inc. announced that it expects to close promptly the previously announced acquisition (“merger”) of the ...

Neurotronic, Inc. announced the first clinical outcomes of the NECTAR III and NECTAR IV trials evaluating the company’s ...

ViTAA Medical Solutions Inc. announced that the FDA has granted 510(k) clearance for the company’s AiORTA Plan. Accor ...

CUC Inc., a provider of health care management and operational support services headquartered in Tokyo, Japan, announced it ...

Johnson & Johnson MedTech announced the 1-year results from the FORWARD PAD study of its Shockwave Javelin peripheral intr ...

In this retrospective cohort study designed to assess long-term safety outcomes of drug-coated devices (DCDs) versus ...

Embolization, Inc. announced that its polymer-based coil intended for arterial and venous embolization in peripheral ...

InterVene, Inc. recently announced that it has received 510(k) clearance from the FDA for its Recana thrombectomy catheter ...

Surmodics, Inc. announced new real-world results from the PROWL registry evaluating the company’s Pounce thrombectomy pl ...

Surmodics, Inc. announced results from a sex-specific analysis of its ongoing PROWL registry evaluating real-world use of the ...